Friday 6 November 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue: +9.98%
EPS: +29.4%
Free cash flow: +6.21%
Total debt: −2.20%

Quarter to September 2026, against a year earlier

254.25 1.43 −0.56%

Follow DGX

Alert me

Market cap: $28.0B
P/E: 25.0×
Fwd P/E: 24.4×
Dividend yield: 1.33%
F-score: 8/9
Altman Z: 3.15
Beneish M: −2.65
Dividend safety: 85/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Quest Diagnostics Incorporated (DGX) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
DIS business	10,785	97.73%
All other operating segments	250	2.27%
Gross margin		33.21%
Operating margin		14.10%
Pre-tax margin		11.94%

Revenue by product or service $m

Line	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Routine clinical testing and other services	4,293 39.79%	3,836 40.65%	4,206 54.44%	4,217 56.00%	4,006 54.12%	3,878 53.76%	4,078 54.42%	4,066 54.69%
Gene-based and esoteric testing services	2,878 26.68%	2,098 22.23%	2,620 33.91%	2,409 31.99%	2,449 33.09%	2,335 32.37%	2,256 30.11%	2,158 29.02%
COVID-19 Testing Services	2,770 25.68%	2,723 28.85%	0 0.00%	0 0.00%	—	—	—	—
Anatomic pathology testing services	553 5.13%	482 5.11%	579 7.49%	578 7.67%	612 8.27%	624 8.65%	631 8.42%	649 8.73%
All other services	294 2.73%	298 3.16%	321 4.15%	327 4.34%	335 4.53%	377 5.23%	528 7.05%	562 7.56%
Revenue	10,788	9,437	7,726	7,531	7,402	7,214	7,493	7,435

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
DIS business	10,785 97.73%	9,614 97.39%	8,976 97.02%	9,609 97.23%	10,494 97.27%	9,139 96.84%	7,405 95.85%	7,204 95.66%	7,068 95.49%	6,837 94.77%	6,965 92.95%	6,873 92.44%	6,587 92.18%	6,820 92.37%	6,812 92.15%	6,737 92.79%	6,824 91.53%
All other operating segments	250 2.27%	258 2.61%	276 2.98%	274 2.77%	294 2.73%	298 3.16%	321 4.15%	327 4.34%	334 4.51%	377 5.23%	528 7.05%	562 7.56%	559 7.82%	563 7.63%	580 7.85%	523 7.21%	631 8.47%
Revenue	11,035	9,872	9,252	9,883	10,788	9,437	7,726	7,531	7,402	7,214	7,493	7,435	7,146	7,383	7,392	7,260	7,455

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
DIS business	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
All other operating segments	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
General corporate activities	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
General Corporate Expenses	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.